1. Individualizing osteoporosis therapy

   • S. Silverman
   • C. Christiansen

   Review 05 January 2012 Pages: 797 - 809

   

2. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008

   • B. Dawson-Hughes
   • A. C. Looker
   • L. J. Melton III

   Original Article 30 June 2011 Pages: 811 - 820

   

3. Rib fracture as a predictor of future fractures in young and older postmenopausal women: National Osteoporosis Risk Assessment (NORA)

   • S. G. Sajjan
   • E. Barrett-Connor
   • E. Siris

   Original Article 09 September 2011 Pages: 821 - 828

   

4. Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008

   • K. Lippuner
   • S. Grifone
   • R. Perrelet

   Original Article 28 May 2011 Pages: 829 - 839

   

5. Measuring health-related quality of life (HRQOL) in osteoporotic males using the Male OPAQ

   • S. L. Solimeo
   • S. L. Silverman
   • D. T. Gold

   Original Article 29 April 2011 Pages: 841 - 852

   

6. A comparative study of using non-hip bone density inputs with FRAX®

   • W. D. Leslie
   • L. M. Lix
   • for the Manitoba Bone Density Program

   Original Article 19 October 2011 Pages: 853 - 860

   

7. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures

   • A. Lalmohamed
   • P. M. J. Welsing
   • F. De Vries

   Original Article Open access 26 November 2011 Pages: 861 - 869

8. Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women

   • E. Y. N. Cheung
   • C. H. Bow
   • A. Kung

   Original Article 12 May 2011 Pages: 871 - 878

   

9. Ethnic difference of clinical vertebral fracture risk

   • C. H. Bow
   • E. Cheung
   • A. W. C. Kung

   Original Article Open access 02 April 2011 Pages: 879 - 885

   

10. Renal function and nonvertebral fracture risk in multiethnic women: the Women’s Health Initiative (WHI)

    • K. E. Ensrud
    • K. Barbour
    • J. A. Cauley

    Original Article 28 May 2011 Pages: 887 - 899

11. The rate of hip osteoarthritis in patients with proximal femoral fractures versus hip contusion

    • B. Robstad
    • F. Frihagen
    • L. Nordsletten

    Original Article Open access 06 April 2011 Pages: 901 - 905

12. A comparison of case-finding strategies in the UK for the management of hip fractures

    • H. Johansson
    • J. A. Kanis
    • E. McCloskey

    Original Article 11 January 2012 Pages: 907 - 915

    

13. The direct cost of acute hip fracture care in care home residents in the UK

    • O. Sahota
    • N. Morgan
    • C. G. Moran

    Original Article 08 May 2011 Pages: 917 - 920

14. Estimation of the lifetime risk of hip fracture for women and men in Canada

    • R. B. Hopkins
    • E. Pullenayegum
    • L. Thabane

    Original Article 11 May 2011 Pages: 921 - 927

    

15. The post-fracture care gap among Canadian First Nations peoples: a retrospective cohort study

    • W. D. Leslie
    • S. L. Brennan
    • B. Elias

    Original Article 03 January 2012 Pages: 929 - 936

    

16. Adiposity and bone health in Spanish adolescents. The HELENA study

    • L. Gracia-Marco
    • F. B. Ortega
    • L. A. Moreno

    Original Article 12 May 2011 Pages: 937 - 947

    

17. Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study

    • S. Tuzun
    • N. Eskiyurt
    • Turkish Osteoporosis Society

    Original Article 19 May 2011 Pages: 949 - 955

    

18. Ankle fractures do not predict osteoporotic fractures in women with or without diabetes

    • J. M. Pritchard
    • L. M. Giangregorio
    • W. D. Leslie

    Original Article 12 May 2011 Pages: 957 - 962

    

19. Low bone mineral density is associated with increased risk for myocardial infarction in men and women

    • P. Wiklund
    • A. Nordström
    • P. Nordström

    Original Article 20 April 2011 Pages: 963 - 970

    

20. PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly

    • A. Arabi
    • R. Baddoura
    • G. El-Hajj Fuleihan

    Original Article 08 June 2011 Pages: 971 - 980

    

21. Relationships between serum vitamin D levels, neuromuscular and neuropsychological function and falls in older men and women

    • J. C. Menant
    • J. C. T. Close
    • S. R. Lord

    Original Article 20 April 2011 Pages: 981 - 989

22. Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden

    • H. Johansson
    • A. Odén
    • D. Mellström

    Original Article 19 October 2011 Pages: 991 - 999

    

23. Predictive values of calcaneal quantitative ultrasound and dual energy X ray absorptiometry for non-vertebral fracture in older men: results from the MrOS study (Hong Kong)

    • T. Kwok
    • C. C. Khoo
    • P. C. Leung

    Original Article 29 April 2011 Pages: 1001 - 1006

24. Identification of prevalent vertebral fractures using CT lateral scout views: a comparison of semi-automated quantitative vertebral morphometry and radiologist semi-quantitative grading

    • Y. M. Kim
    • S. Demissie
    • M. L. Bouxsein

    Original Article 17 September 2011 Pages: 1007 - 1016

    

25. Validated risk rule using computerized data to identify males at high risk for fracture

    • J. LaFleur
    • R. E. Nelson
    • J. R. Nebeker

    Original Article 12 May 2011 Pages: 1017 - 1027

    

26. Association of spinal curve deformity and back extensor strength in elderly women with osteoporosis in Japan and the United States

    • M. Hongo
    • N. Miyakoshi
    • M. Sinaki

    Original Article 01 April 2011 Pages: 1029 - 1034

    

27. Prevalence of non-fracture short vertebral height is similar in premenopausal and postmenopausal women: the osteoporosis and ultrasound study

    • L. Ferrar
    • C. Roux
    • R. Eastell

    Original Article 25 May 2011 Pages: 1035 - 1040

    

28. Treatment for older men with fractures

    • A. J. Shepherd
    • A. R. Cass
    • G. S. Wilkinson

    Original Article 03 August 2011 Pages: 1041 - 1051

29. Adherence to osteoporosis medications amongst Singaporean patients

    • M. H. H. Cheen
    • M. C. Kong
    • M. Chandran

    Original Article 19 April 2011 Pages: 1053 - 1060

    

30. Undertreatment of osteoporosis in persons with dementia? A population-based study

    • Y. Haasum
    • J. Fastbom
    • K. Johnell

    Original Article 16 April 2011 Pages: 1061 - 1068

31. Impact of bone turnover markers and/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial

    • S. L. Silverman
    • K. Nasser
    • B. Drinkwater

    Original Article 14 July 2011 Pages: 1069 - 1074

    

32. Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada

    • A. M. Burden
    • J. M. Paterson
    • S. M. Cadarette

    Original Article Open access 21 May 2011 Pages: 1075 - 1082

    

33. Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis

    • C. Roux
    • D. M. Reid
    • P. N. Sambrook

    Original Article 06 October 2011 Pages: 1083 - 1090

    

34. Arzoxifene versus raloxifene: effect on bone and safety parameters in postmenopausal women with osteoporosis

    • D. L. Kendler
    • S. Palacios
    • J. Zanchetta

    Original Article 04 March 2011 Pages: 1091 - 1101

    

35. The impact of teriparatide adherence and persistence on fracture outcomes

    • S. Yu
    • R. T. Burge
    • E. S. Meadows

    Original Article 08 December 2011 Pages: 1103 - 1113

    

36. Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis

    • J-Y. Reginster
    • J-M. Kaufman
    • C. Roux

    Original Article Open access 29 November 2011 Pages: 1115 - 1122

    

37. Sclerostin levels during growth in children

    • S. Kirmani
    • S. Amin
    • S. Khosla

    Original Article 27 May 2011 Pages: 1123 - 1130

    

38. Dose–response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis

    • T. Nakamura
    • T. Matsumoto
    • M. Shiraki

    Original Article 17 September 2011 Pages: 1131 - 1140

    

39. Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta

    • R. Bargman
    • R. Posham
    • N. Pleshko

    Original Article 08 September 2011 Pages: 1141 - 1150

    

40. Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss

    • A. M. Tyagi
    • K. Srivastava
    • D. Singh

    Original Article 12 May 2011 Pages: 1151 - 1161

    

41. UGT2B17 gene deletion associated with an increase in bone mineral density similar to the effect of hormone replacement in postmenopausal women

    • S. Giroux
    • J. Bussières
    • F. Rousseau

    Original Article 26 May 2011 Pages: 1163 - 1170

42. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide

    • S. A. Polyzos
    • A. D. Anastasilakis
    • E. Terpos

    Short Communication 11 January 2011 Pages: 1171 - 1176

    

43. Low calcidiol levels and risk of progression of aortic calcification

    • M. Naves-Díaz
    • I. Cabezas-Rodríguez
    • J. B. Cannata-Andía

    Short Communication 10 February 2011 Pages: 1177 - 1182

    

44. A limp in a pregnant woman as a first presentation of celiac disease

    • A. A. Jammah

    Case Report 25 May 2011 Pages: 1183 - 1186

    

45. Strontium does accumulate in bone

    • I. Fogelman
    • G. M. Blake

    Letter 14 July 2011 Pages: 1187 - 1187

46. Strontium uptake and effects in bone: reply to Fogelman and Blake

    • P. J. Marie
    • D. Felsenberg
    • M-L. Brandi

    Letter 14 July 2011 Pages: 1189 - 1190